Valeant Pharmaceuticals International Inc. business cards on display in the lobby of the company's headquarters It may be unlikely that Valeant Pharmaceuticals International will actually achieve ...
Valeant Pharmaceuticals International (NYSE:VRX) is a company whose shares are active, trading 2.2% lower to $45.92. The S&P is currently trading 0.9% lower to 1,256 and the Dow Jones Industrial ...
By Market News Video Staff, Friday, December 23, 11:07 AM ET In trading on Friday, shares of Valeant Pharmaceuticals International Inc (NYSE:VRX) crossed above their 200 day moving average of $46 ...
CH Robinson Worldwide, Inc. (NASDAQ: CHRW) had its ?neutral? rating re-affirmed by analysts at Zacks Investment Research. The analysts now have a $72.00 price target on the stock. Cintas (NASDAQ ...
MISSISSAUGA, Ontario, Dec. 12, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE/TSX: VRX) announced today that at a special meeting of shareholders of Afexa Life ...
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an ...
MISSISSAUGA, Ontario, Dec. 12, 2011 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. today announced that the Federal Trade Commission (FTC) voted unanimously to approve the ...
Valeant Receives Approval From FTC In Connection to Acquisition of Dermik (VRX) - Financial News Network Online
Valeant (VRX) Gets FTC Approval for Consent Orders in Dermik, Ortho Dermatologics Acquisitions - StreetInsider.com
NASDAQ
by Jon Ray Moll on December 12, 2011 Cortex Pharmaceuticals (PINK: CORX) percentage change fell -6.33%, to close at $0.0562 and its overall traded volume was 38,625.00 shares during the last ...
LONDON, ONTARIO AND MILTON, ONTARIO, Dec 01, 2011 (MARKETWIRE via COMTEX) -- Stellar Pharmaceuticals Inc. (otcqb:SLXCF) /quotes/zigman/4131233 SLXCF 0.00% (pink sheets:SLXCF) ("Stellar") and ...
Michael Pearson in conversation sounds thoughtful, plain-spoken and driven ? the classic buttoned-down management expert that you might expect someone with 23 years at consulting guru McKinsey ...
Less than two years after severing his links with drug-maker Biovail Corp, Eugene Melnyk is again making headlines with an experimental sexual dysfunction medicine delivered in the form of a nasal ...
Research RS Value A with InvestorGuide.com ETF (exchange traded fund) tool. RSVAX quotes, charts, earnings, ... Biovail Corporation Common Stoc. Hasbro, Inc. Common Stock. Martin ...
Research RS Value A with InvestorGuide.com ETF (exchange traded fund) tool. RSVAX quotes, charts, earnings, ... Biovail Corporation Common Stoc. Hasbro, Inc. Common Stock. Martin ...